Benzphetamine
From Wikipedia, the free encyclopedia
 |
|
|
Benzphetamine
|
|
| Systematic (IUPAC) name | |
| N-benzyl-N-methyl-1-phenyl-propan-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H21N |
| Mol. mass | 239.355 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 75-99% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
CIII |
| Routes | ? |
Benzphetamine (brand name: Didrex) is an anti-obesity drug marketed under this brand in the USA by Pharmacia. Benzphetamine is used as a short term adjunct in management of exogenous obesity. It is closely related to amphetamine.
Benzphetamine is unique in its classification as a Schedule III drug in the United States. (Most members of the amphetamine family are classified in the more highly-regulated Schedule II.) It's notable that benzphetamine is metabolized by the human body into amphetamine and methamphetamine metabolites, making it one of the very few drugs to undergo in vivo conversion to a substance of higher addiction and abuse potential.
{01-Amphetamine/dl-Amphetamine} {02-Dextroamphetamine} {03-Dextromethamphetamine}
no ATC code: {4-FMP} {4-MTA} {Benzphetamine} {MDMA} {MDA} {MDEA} {Paramethoxyamphetamine}
